Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chugai Pharmaceutical | Tokyo | Healthcare | Pharmaceuticals | JP¥11.49T | 28x | 1.08 | JP¥6,979 | 0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 24.3% Upside | Upgrade to Pro+ | |
Takeda Pharmaceutical | Tokyo | Healthcare | Pharmaceuticals | JP¥6.88T | 63.8x | -2.46 | JP¥4,359 | -1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 10% Upside | Upgrade to Pro+ | |
Daiichi Sankyo | Tokyo | Healthcare | Pharmaceuticals | JP¥6.69T | 22.9x | 0.46 | JP¥3,574 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Otsuka Holdings Ltd | Tokyo | Healthcare | Pharmaceuticals | JP¥3.49T | 10.2x | 0.06 | JP¥6,614 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 41.9% Upside | Upgrade to Pro+ | |
Astellas Pharma Inc. | Tokyo | Healthcare | Pharmaceuticals | JP¥2.59T | 51.1x | 0.26 | JP¥1,446.50 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 13.6% Upside | Upgrade to Pro+ | |
Shionogi | Tokyo | Healthcare | Pharmaceuticals | JP¥2.14T | 12.5x | 1.65 | JP¥2,507 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -0.6% Downside | Upgrade to Pro+ | |
Kyowa Kirin | Tokyo | Healthcare | Pharmaceuticals | JP¥1.32T | 25.9x | -0.7 | JP¥2,527 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -5.4% Downside | Upgrade to Pro+ | |
Eisai | Tokyo | Healthcare | Pharmaceuticals | JP¥1.11T | 24.1x | 2.22 | JP¥3,956 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 9.1% Upside | Upgrade to Pro+ | |
Ono Pharmaceutical Ltd | Tokyo | Healthcare | Pharmaceuticals | JP¥760.33B | 15.2x | -0.25 | JP¥1,614.50 | -0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -1.5% Downside | Upgrade to Pro+ | |
Santen Pharmaceutical Co Ltd | Tokyo | Healthcare | Pharmaceuticals | JP¥564.66B | 16.2x | 0.36 | JP¥1,684.50 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 24% Upside | Upgrade to Pro+ | |
Medipal Holdings Corp | Tokyo | Healthcare | Pharmaceuticals | JP¥504.15B | 12.6x | -9.33 | JP¥2,432 | -0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -1.5% Downside | Upgrade to Pro+ | |
Rohto Pharmaceutical | Tokyo | Healthcare | Pharmaceuticals | JP¥468.99B | 15.3x | 89.37 | JP¥2,077 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 30.6% Upside | Upgrade to Pro+ | |
Sumitomo Dainippon Pharma | Tokyo | Healthcare | Pharmaceuticals | JP¥431.06B | 18.2x | 0.17 | JP¥1,084 | 1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -32.2% Downside | Upgrade to Pro+ | |
Suzuken Co Ltd | Tokyo | Healthcare | Pharmaceuticals | JP¥394.61B | 12.2x | 0.42 | JP¥5,522 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -0.6% Downside | Upgrade to Pro+ | |
Toho Holdings | Tokyo | Healthcare | Pharmaceuticals | JP¥303.65B | 15.6x | -16.99 | JP¥4,868 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -9.8% Downside | Upgrade to Pro+ | |
Hisamitsu Pharmaceutical Inc | Tokyo | Healthcare | Pharmaceuticals | JP¥288.5B | 15.1x | 0.38 | JP¥4,049 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 20.7% Upside | Upgrade to Pro+ | |
Tsumura & Co | Tokyo | Healthcare | Pharmaceuticals | JP¥271.86B | 8.5x | 0.09 | JP¥3,633 | 0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -0.8% Downside | Upgrade to Pro+ | |
Sawai Group Holdings Co | Tokyo | Healthcare | Pharmaceuticals | JP¥223.4B | 111.1x | 2.71 | JP¥1,935 | -1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 19.5% Upside | Upgrade to Pro+ | |
Nippon Shinyaku | Tokyo | Healthcare | Pharmaceuticals | JP¥209.35B | 6.4x | 0.25 | JP¥3,104 | -0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 24.7% Upside | Upgrade to Pro+ | |
Torii Pharmaceutical | Tokyo | Healthcare | Pharmaceuticals | JP¥177.7B | 32x | 6.28 | JP¥6,320 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -33.5% Downside | Upgrade to Pro+ | |
Kissei Pharmaceutical | Tokyo | Healthcare | Pharmaceuticals | JP¥174.44B | 15.3x | 1.32 | JP¥4,200 | -1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 11.6% Upside | Upgrade to Pro+ | |
Towa Pharmaceutical | Tokyo | Healthcare | Pharmaceuticals | JP¥157.03B | 8.3x | 0.48 | JP¥3,185 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 31.3% Upside | Upgrade to Pro+ | |
Kaken Pharmaceutical Co Ltd | Tokyo | Healthcare | Pharmaceuticals | JP¥145.52B | 10.5x | 0.15 | JP¥3,843 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 19.5% Upside | Upgrade to Pro+ | |
Mochida Pharmaceutical | Tokyo | Healthcare | Pharmaceuticals | JP¥106.71B | 18.8x | 0.71 | JP¥3,000 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Zeria Pharmaceutical | Tokyo | Healthcare | Pharmaceuticals | JP¥91.55B | 9.2x | 0.32 | JP¥2,075 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 39.2% Upside | Upgrade to Pro+ | |
Kyorin Holdings Inc | Tokyo | Healthcare | Pharmaceuticals | JP¥86.17B | 9.5x | 0.13 | JP¥1,499 | -0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -13.4% Downside | Upgrade to Pro+ | |
JCR Pharmaceuticals | Tokyo | Healthcare | Pharmaceuticals | JP¥81.26B | -17.4x | 0.09 | JP¥668 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -11% Downside | Upgrade to Pro+ | |
Katakura Industries | Tokyo | Healthcare | Pharmaceuticals | JP¥80.59B | 21.1x | 0.64 | JP¥2,553 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Nxera Pharma | Tokyo | Healthcare | Pharmaceuticals | JP¥77.49B | -33.4x | -0.44 | JP¥860 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
ASKA Pharmaceutical Holdings Co | Tokyo | Healthcare | Pharmaceuticals | JP¥68.02B | 13.4x | -0.41 | JP¥2,398 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 5.4% Upside | Upgrade to Pro+ | |
Vital Ksk Holdings | Tokyo | Healthcare | Pharmaceuticals | JP¥59.47B | 8.3x | 0.28 | JP¥1,232 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Cuorips | Tokyo | Healthcare | Pharmaceuticals | JP¥49.45B | -71.8x | -12.29 | JP¥6,000 | -1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Renascience | Tokyo | Healthcare | Pharmaceuticals | JP¥35.29B | 250.3x | 2.17 | JP¥2,618 | -5.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Seikagaku Corp | Tokyo | Healthcare | Pharmaceuticals | JP¥34.77B | 28.6x | -0.63 | JP¥637 | 1.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Daito Pharmaceutical | Tokyo | Healthcare | Pharmaceuticals | JP¥34.21B | 18.2x | -0.45 | JP¥1,140 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Fuji Pharma Co Ltd | Tokyo | Healthcare | Pharmaceuticals | JP¥33.03B | 10.4x | -0.22 | JP¥1,352 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Koa Shoji | Tokyo | Healthcare | Pharmaceuticals | JP¥29.53B | 8x | 0.39 | JP¥700 | -1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Astena Holdings | Tokyo | Healthcare | Pharmaceuticals | JP¥19.46B | -10x | 0.05 | JP¥482 | 0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
CanBas | Tokyo | Healthcare | Pharmaceuticals | JP¥19.44B | -12.7x | 0.48 | JP¥1,018 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
StemRIM | Tokyo | Healthcare | Pharmaceuticals | JP¥19.08B | -1.15 | JP¥306 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
ReproCell | Tokyo | Healthcare | Pharmaceuticals | JP¥18.75B | 180.3x | 0.47 | JP¥199 | -4.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Fuso Pharmaceutical | Tokyo | Healthcare | Pharmaceuticals | JP¥18.23B | 6.6x | 0.06 | JP¥2,129 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
CellSeed | Tokyo | Healthcare | Pharmaceuticals | JP¥16.5B | -9.9x | JP¥475 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Oncolys Biopharma | Tokyo | Healthcare | Pharmaceuticals | JP¥15.43B | -6.7x | -0.53 | JP¥621 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Ohki Healthcare | Tokyo | Healthcare | Pharmaceuticals | JP¥15.13B | 5.7x | 0.28 | JP¥1,109 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Stella Pharma | Tokyo | Healthcare | Pharmaceuticals | JP¥14.23B | -99.4x | -1.22 | JP¥404 | -3.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Taiko Pharmaceutical | Tokyo | Healthcare | Pharmaceuticals | JP¥14B | 19.5x | 0.16 | JP¥278 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Cellsource | Tokyo | Healthcare | Pharmaceuticals | JP¥13.55B | 21.9x | JP¥685 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 28.7% Upside | Upgrade to Pro+ | ||
RaQualia Pharma | Tokyo | Healthcare | Pharmaceuticals | JP¥12.95B | -27.3x | 0.46 | JP¥530 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Harima-Kyowa | Tokyo | Healthcare | Pharmaceuticals | JP¥10.31B | 8x | -0.94 | JP¥1,916 | 1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |